Herpes Simplex Virus Type 2 — A Persistent Problem

Publisher Website
Google Scholar
Abstract
In this issue of the Journal, Fleming and colleagues report that the age-adjusted seroprevalence of herpes simplex virus type 2 (HSV-2) in the United States is now 20.8 percent, an increase of approximately 30 percent over the 13 years between the second and third National Health and Nutrition Examination Surveys (NHANES II and III).1 The obvious inference from the increase in HSV-2 infections is that the spread of sexually transmitted diseases continues unabated, despite the substantial educational efforts made in response to the epidemic of the human immunodeficiency virus (HIV). In NHANES III, HSV-2 seropositivity correlated with a higher lifetime . . .